---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-203750"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2025-09-15T23:59:59+00:00"
generated_at: "2026-05-17T06:39:17.806249+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences raises $9.6M via immediate exercise of existing warrants

## Summary
- $9.6M gross proceeds from exercise of 13,065,000 existing warrants at $2.20/share.
- Issued 13,065,000 new Class I warrants at same $2.20 price, exercisable after stockholder approval for 5 years.
- Existing warrants covered 4,355,000 shares; new warrants cover 13,065,000 shares (higher dilution).
- Proceeds to fund clinical development and working capital.
- Roth Capital Partners acted as financial advisor for 8% cash fee on gross proceeds.

## SEC filing metadata
- accession: 0001193125-25-203750
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2025-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000119312525203750/0001193125-25-203750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000119312525203750/revb-20250911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-203750
- JSON: https://secwatch.observer/filing/0001193125-25-203750.json
- Plain text: https://secwatch.observer/filing/0001193125-25-203750.txt

## Key facts
- Equity Issuances
  REVELATION BIOSCIENCES, INC. issued 13,065,000 new common stock warrants (the "Class I Common Stock Warrants") of warrant to certain holders of existing Class H Common Stock Warrants for exercise of Existing Warrants at $2.20 per share for aggregate gross proceeds of approximately $9.6 million.
  - Security: warrant
  - Shares: 13,065,000 new common stock warrants (the "Class I Common Stock Warrants")
  - Purchaser: certain holders of existing Class H Common Stock Warrants
  - Consideration: exercise of Existing Warrants at $2.20 per share for aggregate gross proceeds of approximately $9.6 million
  source text: On September 10, 2025, Revelation Biosciences, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with certain holders (the “Holders”) of 13,065,000 existing Class H Common Stock Warrants exercisable for an aggregate of 4,355,000 shares of its common stock (collectively, the “Existing Warrants”), to exercise their warrants at an exercise price of $2.20 per share, in exchange for the Company’s agreement to issue 13,065,000 new common stock warrants (the “Class I Common Stock Warrants”) as described below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000119312525203750/0001193125-25-203750-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.